Cargando…
Glycation end-products specific auto-antibodies in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease, which is highly inflammatory. Compared to a healthy control group, SLE patients exhibit a higher concentration of advanced glycation end products (AGEs) and a lower concentration of receptors for AGEs (RAGE) in serum, however, the exact ae...
Autor principal: | Ali Khan, Mohd Wajid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722438/ https://www.ncbi.nlm.nih.gov/pubmed/36518128 http://dx.doi.org/10.6026/97320630018127 |
Ejemplares similares
-
Systemic lupus erythematosus and glycation process
por: NOWAK, AGNIESZKA, et al.
Publicado: (2020) -
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021) -
The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
por: Bobek, Dubravka, et al.
Publicado: (2014) -
Ethnic and gender differences in advanced glycation end products measured by skin auto-fluorescence
por: Mook-Kanamori, Marjonneke J, et al.
Publicado: (2013) -
Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
por: Xu, Shu, et al.
Publicado: (2020)